Biggest News Aggregation in the World
📰 Segments Profiled News

Page 11 - Segments Profiled News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Segments Profiled. Real-time updates on events, politics, business and more.

Breaking New Ground: How Digital Pathology Market will reach US$ 22,870.2 Million by 2032 Transforms

The Digital Pathology Market has witnessed remarkable growth and transformation in recent years, becoming a pivotal component of modern healthcare systems. This innovative field combines cutting-edge technologies, such as whole-slide imaging, artificial intelligence, and cloud computing, to revolutionize traditional...
New York United States Hamamatsu Photonics Leica Biosystems Koninklijke Philips Dhistech Ltd

Empowering Women's Health: The Evolving Cervical Dysplasia Treatment Market is expected to exhibit a CAGR of 4.4% by 2032 | FMI

The Cervical Dysplasia Treatment Market refers to the market for products and services related to the diagnosis and treatment of cervical dysplasia, a condition characterized by abnormal cell growth on the surface of the cervix. Cervical dysplasia is often caused by human papillomavirus (HPV) infection and can progr...
United States New York Market Insights Inc Greater New York Chamber Cervical Dysplasia Treatment In Ambulatory Surgery Centers Hologic Inc

Future Market Insights Study Forecasts Nasal Polyposis Treatment Market to Grow at 6.7% CAGR Until 2

The Nasal Polyposis Treatment Market refers to the pharmaceutical and medical devices market dedicated to providing treatment options for nasal polyposis. Nasal polyposis is a chronic inflammatory condition characterized by the development of benign growths (polyps) in the nasal cavity and sinuses. These polyps can...
United States New York Asia Pacific Nucala Mepolizumab Roche Holding Drug Administration

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Growing Demand for Retinal Vein Occlusion Treatment Drives Market to a Projected 5.9% CAGR till 2033

The Retinal Vein Occlusion Treatment Market refers to the pharmaceuticals and medical devices used to manage and treat retinal vein occlusion, a condition where a vein in the retina becomes blocked or partially blocked. RVO can lead to vision loss or impairment if left untreated.There are two main types of retinal v...
United States New York Branch Retinal Vein Occlusion Retinal Vein Occlusion Treatment Industry Taiwan Liposome Company Market Insights Inc

Transforming Gene Expression | Antisense Oligonucleotides as Game-Changers in Molecular Medicine Mar

The Global Antisense Oligonucleotides Market Revenue is predicted to earn US$ 5,659.2 million in revenue by 2032, up from US$ 1,921.6 million in 2022, at a CAGR of 10.3% during the forecast period.Antisense Oligonucleotides (ASOs) are a promising class of therapeutic agents that hold tremendous potential in the fiel...
New York United States Oligonucleotides Asos Arrowhead Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Market Insights Inc

New Innovations opens Prospects for the Kyphoscoliosis Treatment Market, Propelling the Growth at 5%

The global Kyphoscoliosis Treatment Market Size is expected to witness significant growth in the coming years, driven by factors such as increasing prevalence of kyphoscoliosis, advancements in treatment options, rising healthcare expenditure, increasing awareness about spinal disorders, and technological advancemen...
United States New York Integra Lifesciences B Braun Melsungen Perrigo Company Stryker Corporation

EIA Kits to Hold 53% Market Share for Chronic Hepatitis B Virus Testing Market | FMI Study

During the forecast period 2023 to 2033, the Chronic Hepatitis B Virus Testing Market Sales is expected to grow at a value of 6.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Chronic Hepatitis B Virus Testing is expected to rise up to a market valuation of US$ 1790 Million. Gro...
United States New York Ionis Pharma Arrowhead Pharmaceuticals Hepatitisb Foundation Greater New York Chamber

New Innovations opens Prospects for the Cardiogenic Shock Treatment Market, Propelling the Growth at

The global Market for Cardiogenic Shock Treatment is experiencing significant growth due to a range of factors, including increasing incidence of heart disease, growing adoption of mechanical support devices, and technological advancements in medical devices and therapies. A report published by Future Market Insight...
United States New York Greater New York Chamber Us Food Drug Administration Us Centers For Medicare Medicaid Services Roche Ltd

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science